UC research examines the role of genetics in opioid use disorder
Study identifies genetic variants that could provide therapeutic targets in the future
New research out of the University of Cincinnati examines the association between genetics and the presence of opioid use disorder (OUD). The study identified six single nucleotide polymorphisms (SNPs) or genetic variants that are linked to OUD.
The study was published in the journal Clinical Pharmacology & Therapeutics.
“We are trying to identify some of the genetic variants that might play into OUD,” says Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine and principal investigator for the study. “Patients received an oral swab that gets put inside their cheek, and those swabs were sent off for genetic testing looking for 180 single nucleotide polymorphisms.”
According to the Centers for Disease Control and Protection, more than 107,000 people in the U.S. died in 2021 from drug overdose, with overdose deaths involving synthetic opioids increasing 23% from the year before. The economic cost of OUD and opioid-related overdose mortality exceeds $1 trillion annually in the United States.
The study enrolled about 1,300 patients within three large urban emergency departments in Ohio, which has ranked in the top five for opioid overdose deaths since 2014.
“We wanted to determine for any random person who comes to the emergency department what their genetic link might be and do they now or did they ever have opioid use disorder in their life, and do we think their genetics have played a role in that,” says Freiermuth. “We found that there were quite a few single nucleotide polymorphisms that seem to be associated with opioid use disorder.”
The study found that although genetics play a role in disease, there is also significant interaction from the environment. Freiermuth says further study is needed to highlight the true impact of the genetic variants and how external factors contribute to the development of OUD. Further exploration of biogeographical genetic ancestry groups and their association with OUD is warranted, the study concluded,
“I think this is really exciting because it should help us try to figure out who is truly at risk when they are exposed to opioids and that could make it easier for us to decide who we can and can’t prescribe opioids to,” Freiermuth says. “This could help determine who might need further monitoring in the future instead of just blanket saying ‘nobody should ever get more than a certain amount.'"
Lead image of test tubes/Getty Images/iStockphoto
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Identifying how inflammation affects stroke recovery
October 6, 2022
Researchers at the University of Cincinnati are leading the CAPSTONE study that will learn more about how inflammation affects patient recovery after intracerebral hemorrhage strokes.
Epilepsy trial studies new drug to treat severe seizures
April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
WLWT: UC hosts RESET epilepsy trial
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.